Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
Launched by INDIANA UNIVERSITY · Apr 30, 2015
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the genetic causes of heterotaxy syndrome and related congenital heart defects. Heterotaxy is a condition where the organs in the body are arranged differently than usual, which can also affect the heart. By collecting samples and information from individuals with these conditions and their families, researchers hope to learn more about how these disorders develop. This knowledge could help doctors provide better genetic counseling in the future and improve our understanding of how the body normally develops its left-right symmetry.
To participate in this study, individuals must have heterotaxy or related congenital heart defects, and family members of these individuals are also welcome to join. Unfortunately, those without these conditions or their family members cannot participate. If you decide to join the trial, you can expect to provide some biological samples and personal information that will be used to advance research in this area. This study is currently recruiting, and anyone interested should reach out to learn more about how to get involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with heterotaxy and related congenital heart defects
- • Family members of subjects with heterotaxy and related congenital heart defects
- Exclusion Criteria:
- • Subjects without heterotaxy and related congenital heart defects
- • Family members of subjects without heterotaxy and related congenital heart defects
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Stephanie M. Ware, MD, PhD
Principal Investigator
Indiana University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials